By Staff Writer
AMDL has said that its subsidiary in China, Jade Pharmaceuticals, has set up production and applied for China State Food and Drug Administration approval to market the cancer drug docetaxel.
AMDL said its subsidiary’s sales network is uniquely positioned to take advantage of the significant marketing opportunity in China. Docetaxel is an anticancer drug […]
-
Tags
- Cancer News
- Cancer Story
- breast-cancer
- breast_cancer
- american_cancer_society
- cervical_cancer
- cancer_patients
- journal_cancer
- prostate_cancer
- metastatic_breast_cancer
- cancer_treatment
- colorectal_cancer
- john_edwards
- cervical_cancer_vaccine
- cancer_drugs
- breast_cancer_patients
- colon_cancer
- cancer_vaccine
- word_cancer
- cancer_vaccines
- cancer_therapies
- cancer_researchers
- cancer_deaths
- elizabeth_edwards
- cancer
- breast_cancer_cases
- cancer-drug
- breast_cancer_research
- BREAST-CANCER-RISK
- cancer_center
-
Archives
